Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...

Launching new pharmaceutical products has never been simple, with marketers well aware that a poorly planned and executed initial launch for a new product ... earlier to halt development for ...

In 2023, pharmaceutical companies invested over €460 million in Finland. Half of this was allocated to research and development, with the remainder ... increase in the value of any chemical industry ...

The World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical companies and ...

The decision to expand the development plan follows recently reported promising preclinical findings demonstrating that ...

Expanding international reach remains a key pillar of the government’s strategy, with state-owned pharmaceutical companies actively increasing their presence across Africa, the Middle East, and beyond ...

Building iteration into the product commercialization process can help life sciences companies avoid many of the missteps ...

Download Roadmap The healthcare sector, while focused on improving human health, is a contributor to environmental impacts.

In this exclusive webinar, experts from August Bioservices will discuss the critical factors that make or break a successful ...

In the name of innovation, today's product development teams must focus on the latest trends and technology to push their brand ahead of the competition. However, for a product to truly succeed ...